Organization

Wroclaw Medical University

6 clinical trials

4 abstracts

Abstract
Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL): Updated analysis from a phase I/II study.
Org: F. Hoffmann-La Roche Ltd, Roche Products Ltd., City of Hope National Medical Center, Humanitas University and IRCCS Humanitas Research Hospital, Centre Hospitalier Universitaire de Lille,
Abstract
Impact of pacritinib on symptoms in with thrombocytopenia and myelofibrosis who require red blood cell transfusion.
Org: Washington University School of Medicine in St. Louis, The John Theurer Cancer Center at Hackensack Meridian Health, Wroclaw Medical University, Sobi Inc., Cleveland Clinic Taussig Cancer Institute,
Abstract
BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.
Org: Hospital Paulistano and Instituto Américas, Tom Baker Cancer Centre, Ankara University School of Medicine, MSC National Research Institute of Oncology, Kraków, Poland, Institut Català d'Oncologia Hospitalet,
Abstract
Long-term efficacy of BRAFi/MEKi rechallenge in metastatic melanoma: Report of 9 years of clinical practice.
Org: Maria Sklodowska-Curie National Research Institute of Oncology, Heliodor Swiecicki Clinical Hospital, Holy Cross Cancer Center, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Ludwik Rydygier Collegium Medicum in Bydgoszcz,